Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Seamless Therapeutics logo — Seamless Therapeutics is overcoming the boundaries of gene e...

Seamless Therapeutics

Seamless Therapeutics is overcoming the boundaries of gene editing by unlocking the full potential of recombinases.

Founded 2022 Germany Dresden, Germany 34 employees

General Information

Company Name Seamless Therapeutics
Founded Year 2022
Location Germany Dresden, Germany +2
Employees 34
Social

Get notified when Seamless Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Seamless Therapeutics

Seamless Therapeutics is revolutionizing gene editing by leveraging the potential of recombinases. The company's groundbreaking approach aims to restore health in patients with severe conditions, ensuring precision and safety. By harnessing the reprogramming capabilities of recombinases, Seamless Therapeutics is developing a robust pipeline of disease-modifying product candidates. These initiatives span a wide range of indications, maximizing the therapeutic scope of gene editing. Founded in 2022 and headquartered in Germany, Seamless Therapeutics is poised to make significant strides in the realm of genetic medicine. With a strong focus on innovation and precision, the company is at the forefront of disruptive technologies that have the potential to reshape the future of healthcare.

Taxonomy: gene editing, recombinases, disease-modifying, therapeutics, precision medicine, proprietary technology, medical innovation

No funding data available for Seamless Therapeutics yet.

Get notified when Seamless Therapeutics raises funding

Seamless Therapeutics Alternatives & Competitors

Seamless Therapeutics vs
EdiGene Inc.
EdiGene Inc. China

Edit the Code of Life, Creating Transformative Solutions for Serious Diseases.

Series B
46 employees
Biotechnology, Health Care
Seamless Therapeutics vs
Recombinetics
Recombinetics United States

Delivering the Next Evolution of Healthcare

Series A
17 employees
Biotechnology, Health Care
Seamless Therapeutics vs
Virostem Biotechnology
Virostem Biotechnology Turkey

Gene Editing Technologies and Applications

2 employees
Biotechnology, Life Sciences

FAQ About Seamless Therapeutics

Seamless Therapeutics is overcoming the boundaries of gene editing by unlocking the full potential of recombinases.
Seamless Therapeutics was founded in 2022.
Seamless Therapeutics is headquartered in Dresden, Germany.
Seamless Therapeutics has approximately 34 employees.
Top alternatives and competitors to Seamless Therapeutics include EdiGene Inc., Recombinetics, Virostem Biotechnology, Graphite Bio, CorrectSequence Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Seamless Therapeutics and EdiGene Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Seamless Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy